Published results showed umbilical cord-derived platelet-rich plasma provided better short-term pain relief but similar ...
The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.
A Swedish startup aims to dominate stem cell production while nanotechnology is helping to transform cancer care. What does ...
Clinical Trials Arena on MSN
Parkinson’s stem cell therapy demonstrates promise in Phase II trial
This therapy is one of a few drugs in mid-to-late-stage development for Parkinson’s that has displayed disease-modifying ...
Hope is preparing for close-out meetings with the FDA. Chang said the team is “hopeful to advance to a phase 3 confirmatory trial” of the stem cell therapy candidate.
Canadian Patent No. 3043594, entitled “Method of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral Immunity,” provides Longeveron with patent rights in Canada through 2037.
In a Liv Hospital study, stem cell therapy improved heart function dramatically using MSCs and EVs, despite a blocked graft.
Multipotent dental stem cells can give rise to various cell types and show potential for treating injuries, diabetes, and heart disease in early clinical trials.
As head team physician for the New York Giants, I routinely have athletes asking about supposed ‘breakthrough’ stem cell treatments,” writes Scott Rodeo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results